Alejandra de Moreno de LeBlanc

Alejandra de Moreno de LeBlanc

Auto-generated profile, based on publicly available information

Alejandra de Moreno de LeBlanc

Centro de Referencia para Lactobacilos (CERELA-CONICET), Chacabuco 145, (T4000ILC) San Miguel de Tucumán, Tucumán, Argentina

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2011 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
NCNatalia A Castillo
Natalia A Castillo
GPGabriela Perdigón
Gabriela Perdigón
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc
Background: Diarrheal infections caused bySalmonella, are one of the major causes of childhood morbidity and mortality in developing countries.Salmonellacauses various diseases that range from mild gastroenteritis to enteric fever, depending on the serovar involved, infective dose, species, age and immune status of the host. Probiotics are proposed as an attractive alternative possibility in the prevention against this pathogen infection. Previously we demonstrated that continuousLactobacillus caseiCRL 431 administration to BALB/c mice before and after challenge withSalmonella entericaserovar Typhimurium (S. Typhimurium) decreased the severity ofSalmonellainfection. The aim of the present work was to deep into the knowledge about how this probiotic bacterium exerts its effect, by assessing its impact on the expression and secretion of pro-inflammatory (TNFα, IFNγ) and anti-inflammatory (IL-10) cytokines in the inductor and effector sites of the gut immune response, and analyzing toll-like receptor (TLR2, TLR4, TLR5 and TLR9) expressions in both healthy and infected mice.Results: Probiotic administration to healthy mice increased the expression of TLR2, TLR4 and TLR9 and improved the production and secretion of TNFα, IFNγ and IL-10 in the inductor sites of the gut immune response (Peyer's patches). Post infection, the continuous probiotic administration, before and afterSalmonellachallenge, protected the host by modulating the inflammatory response, mainly in the immune effector site of the gut, decreasing TNFα and increasing IFNγ, IL-6 and IL-10 production in the lamina propria of the small intestine.Conclusions: The oral administration ofL. caseiCRL 431 induces variations in the cytokine profile and in the TLRs expression previous and also after the challenge withS. Typhimurium. These changes show some of the immune mechanisms implicated in the protective effect of this probiotic strain againstS. Typhimurium, providing an alternative way to reduce the severity of the infection.

1 February 2011 in Journal of Biotechnology
Verified
Journal Article
Closed access
JBJean Guy Le Blanc
Jean Guy Le Blanc
SCSilvina del Carmen
Silvina del Carmen
AMAnderson Miyoshi
Anderson Miyoshi
VAVasco Azevedo
Vasco Azevedo
FSFernando Sesma
Fernando Sesma
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc

9 January 2016 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
MLMarion Lenoir
Marion Lenoir
SCSilvina del Carmen
Silvina del Carmen
NCNaima G. Cortes-Perez
Naima G. Cortes-Perez
DODaniel Lozano Ojalvo
Daniel Lozano Ojalvo
DMDiego Muñoz-Provencio
Diego Muñoz-Provencio
Luis Bermudez HumaránLuis Bermudez Humarán
Luis Bermudez Humarán

1 January 2008 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
PDF file
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc
JBJean Guy Le Blanc
Jean Guy Le Blanc
GPGabriela Perdigón
Gabriela Perdigón
AMAnderson Miyoshi
Anderson Miyoshi
PLPhilippe Langella
Philippe Langella
FSFernando Sesma
Fernando Sesma
Reactive oxygen species, such as hydrogen peroxide (H2O2), are involved in various aspects of tumour development. Decreasing their levels can therefore be a promising approach for colon cancer prevention. The objective of this study was to evaluate the effect of catalase-producing Lactococcus lactis on the prevention of an experimental murine 1,2-dimethylhydrazine (DMH)-induced colon cancer. DMH-treated BALB/c mice received either a catalase-producing L. lactis strain or the isogenic non-catalase-producing strain as a control, whereas other untreated mice did not receive bacterial supplementation. Catalase activity and H2O2 levels in intestinal fluids and blood samples were measured, and changes in the histology of the large intestines during tumour progression were evaluated. The catalase-producing L. lactis strain used in this study was able to slightly increase catalase activities in DMH-treated mice (1.19±0.08 U ml−1) and reduce H2O2 levels (3.4±1.1 μM) compared to (i) animals that received the non-catalase-producing strain (1.00±0.09 U ml−1, 9.0±0.8 μM), and (ii) those that did not receive bacterial supplementation (1.06±0.07 U ml−1, 10.0±1.1 μM). Using the histopathological grading scale of chemically induced colorectal cancer, animals that received the catalase-producing L. lactis had a significantly lesser extent of colonic damage and inflammation (2.0±0.4) compared to animals that received the non-catalase-producing L. lactis (4.0±0.3) or those that did not receive bacterial supplementation (4.7±0.5). The catalase-producing L. lactis strain used in this study was able to prevent tumour appearance in an experimental DMH-induced colon cancer model.

8 February 2011 in ISRN Gastroenterology
Verified
Journal Article
Open access
PDF file
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc
SCSilvina del Carmen
Silvina del Carmen
MZMeritxell Zurita-Turk
Meritxell Zurita-Turk
CRClarissa Santos Rocha
Clarissa Santos Rocha
MGMaarten van de Guchte
Maarten van de Guchte
JBJean Guy Le Blanc
Jean Guy Le Blanc
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of one of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of gastrointestinal inflammatory disease through their immune-modulating properties. A special emphasis will be placed on the critical role of the anti-inflammatory cytokine IL-10, and a brief overview of the uses of genetically engineered LAB that produce this important immune response mediator will also be discussed. Thus, this paper will demonstrate the critical role that IL-10 plays in gastrointestinal inflammatory diseases and how probiotics could be used in their treatment.

26 April 2005 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc
CMChantal Matar
Chantal Matar
NLNicole LeBlanc
Nicole LeBlanc
GPGabriela Perdigón
Gabriela Perdigón
Introduction: Antitumour activity is one of the health-promoting effects attributed to the lactic acid bacteria and their products of fermentation. Previous studies in mice demonstrated that bioactive compounds released in milk fermented by Lactobacillus helveticus R389 contribute to its immunoenhancing and antitumour properties. The aim of the present work was to study the effects of the consumption of milk fermented by L. helveticus R389 or its proteolytic-deficient variant, L. helveticus L89, on a murine hormone-dependent breast cancer model. Methods: Mice were fed with milk fermented by L. helveticus R389 or L. helveticus L89, during 2 or 7 days. The tumour control group received no special feeding. At the end of the feeding period, the mice were challenged by a subcutaneous injection of tumour cells in the mammary gland. Four days post-injection, the mice received fermented milk on a cyclical basis. The rate of tumour development and the cytokines in serum, mammary gland tissue and tumour-isolated cells were monitored. Bcl-2-positive cells in mammary glands and cellular apoptosis in tumour tissue were also studied. Results: Seven days of cyclical administration of milk fermented by either bacterial strain delayed or stopped the tumour development. Cytokines demonstrated that L. helveticus R389 modulated the immune response challenged by the tumour. IL-10 and IL-4 were increased in all the samples from this group. In comparison with the tumour control, all test groups showed a decrease of IL-6, a cytokine involved in oestrogen synthesis. Seven days of cyclical feeding with milk fermented by L. helveticus R389 produced an increase in the number of apoptotic cells, compared with all other groups. Conclusion: This study demonstrated that 7 days of cyclical administration of milk fermented by both strains of L. helveticus diminishes tumour growth, stimulating an antitumour immune response. Compounds released during milk fermentation with L. helveticus R389 would be implicated in its immunoregulatory capacity on the immune response in mammary glands and tumour, which were correlated with the cytokines found at the systemic level. The milk fermented by L. helveticus R389 was able to modulate the relationship between immune and endocrine systems (by IL-6 diminution), which is very important in oestrogen-dependent tumour and induced cellular apoptosis.